TY - JOUR
T1 - Extraskeletal myxoid chondrosarcoma with rhabdoid features, with special reference to its aggressive behavior
AU - Oshiro, Yumi
AU - Shiratsuchi, Hideki
AU - Tamiya, Sadafumi
AU - Oda, Yoshinao
AU - Toyoshima, Satoshi
AU - Tsuneyoshi, Masazumi
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2000/4
Y1 - 2000/4
N2 - The presence of rhabdoid cells has been reported in Various types of malignant neoplasms. Thirty-six cases of extraskeletal myxoid chondrosarcoma (EMC) were reviewed, and three of them revealed rhabdoid features. These cases contained cells having prominent eosinophilic globular cytoplasm, but were otherwise typical of EMC. Immunohistochemically, cytokeratin (CAM 5.2) was positive in three of 20 cases (15%), including two of the three with rhabdoid features. The rhabdoid cells were also immunostained with vimentin. The 5-year survival rate in the 26 cases with follow-up information was 73%, and the 10-year survival rate was 63%. The cases with rhabdoid features had a significantly poorer prognosis (p=0.0271). This study suggests that presence of rhabdoid features is a predictor of aggressive behavior in EMC, as it was shown to be in other mesenchymal neoplasms.
AB - The presence of rhabdoid cells has been reported in Various types of malignant neoplasms. Thirty-six cases of extraskeletal myxoid chondrosarcoma (EMC) were reviewed, and three of them revealed rhabdoid features. These cases contained cells having prominent eosinophilic globular cytoplasm, but were otherwise typical of EMC. Immunohistochemically, cytokeratin (CAM 5.2) was positive in three of 20 cases (15%), including two of the three with rhabdoid features. The rhabdoid cells were also immunostained with vimentin. The 5-year survival rate in the 26 cases with follow-up information was 73%, and the 10-year survival rate was 63%. The cases with rhabdoid features had a significantly poorer prognosis (p=0.0271). This study suggests that presence of rhabdoid features is a predictor of aggressive behavior in EMC, as it was shown to be in other mesenchymal neoplasms.
UR - http://www.scopus.com/inward/record.url?scp=0034048543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034048543&partnerID=8YFLogxK
U2 - 10.1177/106689690000800209
DO - 10.1177/106689690000800209
M3 - Article
AN - SCOPUS:0034048543
SN - 1066-8969
VL - 8
SP - 145
EP - 152
JO - International Journal of Surgical Pathology
JF - International Journal of Surgical Pathology
IS - 2
ER -